Skip to main content
. Author manuscript; available in PMC: 2016 Jan 7.
Published in final edited form as: J Transl Sci. 2015 Jul 30;1(1):http://oatext.com/Molecular-analysis-of-CD133-positive-circulating-tumor-cells-from-patients-with-metastatic-castration-resistant-prostate-cancer.php.

Figure 4.

Figure 4

CD133neg and CD133pos CTCs have comparable levels of androgen receptor protein expression. A. Representative dot plot showing androgen receptor (AR) gating strategy of CD133neg and CD133pos CTCs. B. Representative ImageStreamX images of CD133neg and CD133pos CTCs showing ARhigh and ARlow cells. C. Box-and-whisker plot comparing patients’ median AR intensity of their CD133neg versus CD133pos CTCs (n=19; N.S. = not statistically significant from Wilcoxon signed-rank test).